Sona Koyo Steering Systems has reported a consolidated total income from operations of Rs 389.18 crore and a net profit of Rs 6.66 crore for the quarter ended Sep ’15
Posts tagged MC
Sona Koyo Stee consolidated Sep ’15 sales at Rs 389.18 crore (18-11-2015)
How a global solar drive will boost silver prices (18-11-2015)
Silver, a key component of solar cells as it is the best metallic conductor of heat and electricity, has seen a slump in prices to a three-month low this week in line with a broad-based decline in gold prices.
Sensex, Nifty sluggish; IT stocks drag, Cap Goods index up (18-11-2015)
Coal India, NTPC, GAIL, Tata Motors and Cipla are top gainers while Infosys, Hindalco, Dr Reddy’s Labs, Vedanta and Tata Steel are among losers.
Now pay min fare of Rs 10 for Mumbai non-suburb train ride (18-11-2015)
The platform ticket price was revised from Rs 5 to Rs 10 in April this year as proposed in the rail budget with a view to control the rush on platforms.
Fresh shootout during anti-terrorist operation in Paris (18-11-2015)
There was an exchange of gunfire during the operation in Saint-Denis, according to a source close to the investigation, who could not confirm who was targeted in the operation. Another source said a special armed response unit took part in the raid.
Nifty struggles below 7850; Coal India up 2%, HUL gains (18-11-2015)
Coal India, NTPC, Bharti Airtel, GAIL and HUL are top gainers while Infosys, Dr Reddy’s, Vedanta, Maruti and Hindalco.
7th Pay Commission to boost consumer durable demand: Nomura (18-11-2015)
Sources say that the Seventh Pay Commission report will suggest a 15 percent hike in salaries, much lower than the expected 35 percent jump.
Not received warning from USFDA on Clovis: Dishaman Pharma (18-11-2015)
JR Vyas, CMD, Dishman Pharma in an interview to CNBC-TV18 clarified that the company had not received any warning from US FDA on Clovis issue.
Not received warning from USFDA on Clovis: Dishman Pharma (18-11-2015)
JR Vyas, CMD, Dishman Pharma in an interview to CNBC-TV18 clarified that the company had not received any warning from US FDA on Clovis issue.
Demand pick-up visible; eye 12% growth in H2FY16: Bhargava (18-11-2015)
Maruti Suzuki’s RC Bhargava is confident of 12 percent growth in second half of the year with uptick in retail demand.